Evidence map›Paper›PMID 28347089›Full record

ReviewNanomaterials (Basel, Switzerland)2015

Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy.

Mathangi Srinivasan, Mehdi Rajabi, Shaker A Mousa

Open access · goldAbstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 153 citations in OpenAlex.

  1. Amine-Functionalized and Gold-Decorated Amine-Functionalized TiOInternational journal of molecular sciences · 2026
    Article
  2. Navigating theNanoscale advances · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. ACS omega · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Biosynthesis of ternary NiCoFeJournal of biological engineering · 2023
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mathangi SrinivasanThe Pharmaceutical Research Institute, 1 Discovery Drive, Rensselaer, NY 12144, USA. mathangi.srinivasan@acphs.edu.
Mehdi RajabiThe Pharmaceutical Research Institute, 1 Discovery Drive, Rensselaer, NY 12144, USA. mehdi.rajabi@acphs.edu.
Shaker A MousaThe Pharmaceutical Research Institute, 1 Discovery Drive, Rensselaer, NY 12144, USA. shaker.mousa@acphs.edu.
Albany College of Pharmacy and Health Sciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The field of nanotechnology has led to the development of many innovative strategies for effective detection and treatment of cancer, overcoming limitations associated with conventional cancer diagnosis and therapy. Multifunctional nanoparticle systems can integrate imaging, targeting and treatment moieties on the surface and in the core, resulting in targeted delivery of the imaging or treatment modalities, specifically to the tumor. Multifunctional nanoparticles also enable simultaneous delivery of multiple treatment agents, resulting in effective combinatorial therapeutic regimens against cancer. In this review, various multifunctional nanoparticle systems that feature a variety of targeting moieties for

Indexed as

cancer therapydrug deliveryimagingmultifunctional nanoparticlesnanotechnologytumor targeting

Identifiers

PMID28347089
PMCPMC5304767
OpenAlexW1691566585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.